Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
US5852059A · kind A · utility
15Cited by
5References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 6, 1997 |
| Grant date | Dec 22, 1998 |
| Priority date | — |
| Expiry date | Jan 6, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a method for treating a condition or disease selected from endometriosis, obesity, benign prostatic hypertrophy and prostatic carcinoma in mammals which comprises administering to said mammal an amount of droloxifene or a pharmaceutically acceptable salt thereof which is effective in treating said condition or disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.